Page last updated: 2024-08-24

gemcitabine and Pain

gemcitabine has been researched along with Pain in 35 studies

Research

Studies (35)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	4 (11.43)	18.2507
2000's	14 (40.00)	29.6817
2010's	14 (40.00)	24.3611
2020's	3 (8.57)	2.80

Authors

Authors	Studies
Komatsu, Y; Saito, Y; Sakamoto, T; Sugawara, M; Takekuma, Y; Uchiyama, K	1
Ido, S; Kawazoe, H; Matsuo, M; Mori, N; Nakai, M; Nakamura, T; Sumikawa, S; Takeuchi, A; Tsuneoka, K; Uozumi, R; Yakushijin, Y; Yamauchi, M	1
Dieudé, P; Forien, M; Gounant, V; Jelin, G; Ottaviani, S; Palazzo, E; Pina Vegas, L	1
Abou-Elela, E; Darwish, D; Ibrahim, N	1
Kakudo, Y; Kameno, K; Kanai, M; Kim, YH; Kitano, T; Matsumoto, S; Mishima, M; Mori, Y; Nagai, H; Nakata, K; Nishimura, T; Sato, H; Takashima, S; Yamaguchi, T; Yanagihara, K; Yasuda, H	1
Hiramatsu, Y; Shibahara, H	1
Becker, G; Gaertner, J	1
Bernhard, J; Bodoky, G; Dietrich, D; Glimelius, B; Herrmann, R; Scheithauer, W	1
Bottomley, A; Coens, C; Ediebah, DE; Flechtner, H; Gotay, C; Greimel, E; King, MT; Quinten, C; Reeve, BB; Ringash, J; Schmucker von Koch, J; Smit, EF; Taphoorn, MJ; Weis, J; Zikos, E	1
Anthoney, A; Archer, C; Corrie, P; Costello, E; Cox, T; Coxon, F; Cunningham, D; Eatock, M; Evans, J; Falk, S; Garcia-Alonso, A; Greenhalf, W; Harrison, M; Hickish, T; Iveson, T; Madhusudan, S; McAdam, K; Middleton, G; Naisbitt, D; Nanson, G; Neoptolemos, J; Nicolson, M; Propper, D; Rawcliffe, C; Robinson, A; Roques, T; Ross, P; Shaw, V; Silcocks, P; Steward, W; Valle, J; Wadd, N; Wadsley, J	1
Bowman, L; John, W; Liepa, AM; Melemed, A; Peterson, P; Shen, W; Smyth, EN	1
Bajetta, E; Bauer, J; Bernhard, J; Bodoky, G; Dietrich, D; Figer, A; Gerber, D; Glimelius, B; Herrmann, R; Koeberle, D; Köhne, CH; Kornek, GV; Mingrone, W; Pestalozzi, BC; Ruhstaller, T; Saletti, P; Scheithauer, W; Schüller, J; Stemmer, SM; Tàmas, K	1
Beretta, K; Borner, M; Caspar, CB; Dietrich, D; Gerber, D; Herrmann, R; Koeberle, D; Mingrone, W; Mora, O; Ruhstaller, T; Saletti, P; Strasser, F	1
Bouche, O; Bugat, R; De Porre, P; Eckhardt, SG; Maurel, J; Michiels, B; Smith, D; Steward, WP; van de Velde, H	1
Bentzen, L; Buch-Hansen, TZ; Hansen, S; Hoeyer, M; Jensen, NV; Saxe, C; Sengeloev, L	1
Benedetti, J; Blanke, CD; Flynn, PJ; Goldman, B; Lippman, SM; Millwood, B; Moinpour, CM; O'Reilly, EM; Philip, PA; Redman, MW; Rowland, KM; Seay, TE; Vaught, NL; Wong, RP	1
Ballal, S; Dicke, K; Gurtler, J; Katz, T; Kayaleh, O; Keaton, M; Ko, AH; Lenz, HJ; Rowinsky, EK; Youssoufian, H	1
Archer, L; Basch, E; Kindler, HL; Niedzwiecki, D; Romanus, D; Schrag, D; Weeks, J	1
Hosokawa, A; Kiba, T; Kozawa, K; Nakashima, T; Ogawa, Y	1
Kanetake, H; Matsuo, T; Miyata, Y; Nomata, K; Ohba, K; Sagara, Y; Sakai, H	1
Agelaki, S; Androulakis, N; Aravantinos, G; Dimopoulos, MA; Foutzilas, G; Georgoulias, V; Giannakakis, T; Janninis, D; Kouroussis, C; Rigatos, SK; Stathopoulos, GP; Stathopoulos, JG	1
Bosquée, L; D'Odemont, JP; Dams, N; Delobbe, A; Deman, R; Deschepper, K; Dooms, C; Galdermans, D; Nackaerts, K; Siemons, L; Van den Brande, P; Van Kerckhoven, W; Vandebroek, J; Vandeurzen, K; Vansteenkiste, J	1
Büchler, MW; di Mola, FF; Di Sebastiano, P; Felix, K; Friess, H; Giese, NA; Hartel, M; Hinz, U; Mascetta, G; Selvaggi, F; Wente, MN	1
Albritton, K; Anderson, PM; Dubansky, SA; Erlandson, L; Rodriguez, V; Trotz, B; Wiseman, GA	1
Abdelatif, M; Bidault, F; Bouvet-Forteau, N; de Crevoisier, R; di Palma, M; Fizazi, K; Laplanche, A; Theodore, C; Wibault, P	1
Funakoshi, A; Sumii, T	1
Azzoni, P; Cetto, GL; Genestreti, G; Manno, P; Micciolo, R; Molino, A; Pattaro, C; Santo, A; Sava, T; Terzi, A	1
Fayad, LE; Goy, A; Hagemeister, F; McLaughlin, P; Neelapu, S; Oki, Y; Pro, B; Romaguera, J; Samaniego, F; Younes, A	1
Rothenberg, ML	1
Burris, HA	1
Andersen, J; Burris, HA; Cripps, MC; Dorr, FA; Green, MR; Modiano, MR; Moore, MJ; Nelson, R; Portenoy, RK; Rothenberg, ML; Stephens, CD; Storniolo, AM; Tarassoff, P; Von Hoff, DD	1
Caraceni, A; De Conno, F	1
Delpon, A; Dupuis, O; Ganem, G; Joffroy, A; Solal-Celigny, P; Tassy, D	1
Alberts, SR; Jacobson, SD; O'Connell, MJ	1
Aravantinos, G; Bafaloukos, D; Dimopoulos, MA; Kalofonos, H; Kiamouris, C; Nicolaides, C; Pectasides, D; Visvikis, A; Xiros, N	1

Reviews

3 review(s) available for gemcitabine and Pain

Article	Year
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine. Lung cancer (Amsterdam, Netherlands), 2003, Volume: 40, Issue:2 Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Gemcitabine; Humans; Karnofsky Performance Status; Lung Neoplasms; Pain; Quality of Life; Time Factors; Treatment Outcome; Vindesine	2003
New developments in chemotherapy for patients with advanced pancreatic cancer. Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:9 Suppl Topics: Analgesics; Antimetabolites, Antineoplastic; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Pain; Pancreatic Neoplasms	1996
Pancreatic cancer in the older patient. Oncology (Williston Park, N.Y.), 2001, Volume: 15, Issue:7 Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Cholestasis; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Pain; Pain Management; Palliative Care; Pancreatic Neoplasms	2001

Trials

19 trial(s) available for gemcitabine and Pain

Article	Year
Use of glucose solution for the alleviation of gemcitabine-induced vascular pain: a double-blind randomized crossover study. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2013, Volume: 21, Issue:12 Topics: Adult; Antimetabolites, Antineoplastic; Cross-Over Studies; Deoxycytidine; Double-Blind Method; Female; Gemcitabine; Glucose; Humans; Infusions, Parenteral; Male; Middle Aged; Neoplasms; Pain; Pain Measurement; Vascular Diseases	2013
Clinical benefit response in pancreatic cancer trials revisited. Oncology research and treatment, 2014, Volume: 37, Issue:1-2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Capecitabine; Causality; Comorbidity; Deoxycytidine; Disease-Free Survival; Drug Therapy; Female; Fluorouracil; Gemcitabine; Humans; Incidence; Karnofsky Performance Status; Longitudinal Studies; Male; Middle Aged; Outcome Assessment, Health Care; Pain; Palliative Care; Pancreatic Neoplasms; Quality of Life; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Survival Rate; Treatment Outcome	2014
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trial. The Lancet. Oncology, 2014, Volume: 15, Issue:8 Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Cancer Vaccines; Capecitabine; Cell Proliferation; Deoxycytidine; Disease-Free Survival; Fatigue; Female; Fluorouracil; Gemcitabine; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Immunologic Factors; Intention to Treat Analysis; Kaplan-Meier Estimate; Male; Middle Aged; Neutropenia; Pain; Pancreatic Ducts; Pancreatic Neoplasms; Peptide Fragments; T-Lymphocytes; Telomerase	2014
Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer. Health and quality of life outcomes, 2016, Mar-25, Volume: 14 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Breast Neoplasms; Deoxycytidine; Drug-Related Side Effects and Adverse Reactions; Female; Gemcitabine; Humans; Middle Aged; Paclitaxel; Pain; Pain Measurement; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Quality of Life; Treatment Outcome	2016
Clinical benefit and quality of life in patients with advanced pancreatic cancer receiving gemcitabine plus capecitabine versus gemcitabine alone: a randomized multicenter phase III clinical trial--SAKK 44/00-CECOG/PAN.1.3.001. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Aug-01, Volume: 26, Issue:22 Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Aged, 80 and over; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Capecitabine; Deoxycytidine; Drug Administration Schedule; Europe; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Parenteral; Karnofsky Performance Status; Male; Middle Aged; Pain; Pain Measurement; Pancreatic Neoplasms; Prospective Studies; Quality of Life; Time Factors; Treatment Failure	2008
Patient-reported outcomes of patients with advanced biliary tract cancers receiving gemcitabine plus capecitabine: a multicenter, phase II trial of the Swiss Group for Clinical Cancer Research. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2008, Aug-01, Volume: 26, Issue:22 Topics: Administration, Oral; Adult; Aged; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Capecitabine; Deoxycytidine; Disease Progression; Female; Fluorouracil; Gemcitabine; Humans; Infusions, Intravenous; Karnofsky Performance Status; Male; Middle Aged; Neoplasm Staging; Pain; Pain Measurement; Palliative Care; Quality of Life; Switzerland; Time Factors; Treatment Outcome	2008
Patient-reported outcomes as a component of the primary endpoint in a double-blind, placebo-controlled trial in advanced pancreatic cancer. Journal of pain and symptom management, 2009, Volume: 37, Issue:2 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Deoxycytidine; Double-Blind Method; Europe; Female; Gemcitabine; Humans; Incidence; Male; Middle Aged; Outcome Assessment, Health Care; Pain; Pain Measurement; Pancreatic Neoplasms; Patient Satisfaction; Placebo Effect; Quinolones; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome; United States	2009
Phase I/II study on docetaxel, gemcitabine and prednisone in castrate refractory metastatic prostate cancer. Cancer chemotherapy and pharmacology, 2010, Volume: 66, Issue:2 Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Docetaxel; Endpoint Determination; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Neoplasm Metastasis; Orchiectomy; Pain; Palliative Care; Prednisone; Prostatic Neoplasms; Survival Analysis; Taxoids	2010
Pain and emotional well-being outcomes in Southwest Oncology Group-directed intergroup trial S0205: a phase III study comparing gemcitabine plus cetuximab versus gemcitabine as first-line therapy in patients with advanced pancreas cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2010, Aug-01, Volume: 28, Issue:22 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Attitude to Health; Cetuximab; Deoxycytidine; Female; Gemcitabine; Humans; Male; Mental Health; Middle Aged; Pain; Pancreatic Neoplasms; Quality of Life	2010
A phase II randomized study of cetuximab and bevacizumab alone or in combination with gemcitabine as first-line therapy for metastatic pancreatic adenocarcinoma. Investigational new drugs, 2012, Volume: 30, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cetuximab; Deoxycytidine; Female; Gemcitabine; Humans; Male; Middle Aged; Neoplasm Metastasis; Pain; Pancreatic Neoplasms; Quality of Life; Treatment Outcome	2012
Does health-related quality of life improve for advanced pancreatic cancer patients who respond to gemcitabine? Analysis of a randomized phase III trial of the cancer and leukemia group B (CALGB 80303). Journal of pain and symptom management, 2012, Volume: 43, Issue:2 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxycytidine; Double-Blind Method; Female; Gemcitabine; Humans; Male; Middle Aged; Pain; Palliative Care; Pancreatic Neoplasms; Prevalence; Quality of Life; Risk Assessment; Risk Factors; Survival Analysis; Survival Rate; Treatment Outcome; United States	2012
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:3 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Infusions, Intravenous; Irinotecan; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Pain; Pancreatic Neoplasms; Survival Analysis; Thrombocytopenia; Treatment Outcome	2003
Influence of cisplatin-use, age, performance status and duration of chemotherapy on symptom control in advanced non-small cell lung cancer: detailed symptom analysis of a randomised study comparing cisplatin-vindesine to gemcitabine. Lung cancer (Amsterdam, Netherlands), 2003, Volume: 40, Issue:2 Topics: Age Factors; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Deoxycytidine; Disease Progression; Gemcitabine; Humans; Karnofsky Performance Status; Lung Neoplasms; Pain; Quality of Life; Time Factors; Treatment Outcome; Vindesine	2003
A phase II monocentric study of oxaliplatin in combination with gemcitabine (GEMOX) in patients with advanced/metastatic transitional cell carcinoma (TCC) of the urothelial tract. Annals of oncology : official journal of the European Society for Medical Oncology, 2006, Volume: 17, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Deoxycytidine; Double-Blind Method; Drug Administration Schedule; Gemcitabine; Humans; Infusions, Intravenous; Organoplatinum Compounds; Oxaliplatin; Pain; Pain Measurement; Placebos; Treatment Outcome; Urologic Neoplasms	2006
Gemcitabine (GEM) and vindesine (VDS) in advanced non-small cell lung cancer (NSCLC): a phase II study in elderly or poor performance status patients. Lung cancer (Amsterdam, Netherlands), 2006, Volume: 53, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Middle Aged; Pain; Time Factors; Treatment Outcome; Vindesine	2006
Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma. Cancer, 2008, Feb-15, Volume: 112, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neutropenia; Pain; Rituximab; Survival Analysis; Treatment Outcome	2008
Objective outcome measures of quality of life. Oncology (Williston Park, N.Y.), 1996, Volume: 10, Issue:11 Suppl Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Fluorouracil; Gemcitabine; Humans; Karnofsky Performance Status; Pain; Pancreatic Neoplasms; Quality of Life; Survival Analysis; Treatment Outcome	1996
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:6 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Infusion Pumps; Male; Middle Aged; Morphine; Narcotics; Pain; Pancreatic Neoplasms; Survival Rate; Treatment Outcome	1997
Combination chemotherapy with gemcitabine and ifosfamide as second-line treatment in metastatic urothelial cancer. A phase II trial conducted by the Hellenic Cooperative Oncology Group. Annals of oncology : official journal of the European Society for Medical Oncology, 2001, Volume: 12, Issue:10 Topics: Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Hematuria; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Metastasis; Neutropenia; Pain; Salvage Therapy; Thrombocytopenia; Treatment Outcome; Urination Disorders; Urologic Neoplasms	2001

Other Studies

14 other study(ies) available for gemcitabine and Pain

Article	Year
A 5% Glucose Solution for the Liquid Formulation Gemcitabine Solvent Decreases Gemcitabine-induced Vascular Pain. Anticancer research, 2022, Volume: 42, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Blood Vessels; Deoxycytidine; Female; Gemcitabine; Glucose; Humans; Male; Middle Aged; Pain; Pancreatic Neoplasms	2022
Liquid Formulation of Gemcitabine Increases Venous Pain in Patients With Cancer: A Retrospective Study. Clinical therapeutics, 2020, Volume: 42, Issue:4 Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Compounding; Female; Freeze Drying; Gemcitabine; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Pain; Retrospective Studies; Risk Factors	2020
Groin Pain After Gemcitabine for Lung Cancer. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases, 2021, Dec-01, Volume: 27, Issue:8S Topics: Deoxycytidine; Gemcitabine; Groin; Humans; Lung Neoplasms; Pain	2021
Survival of mesothelioma in a palliative medical care unit in egypt. Asian Pacific journal of cancer prevention : APJCP, 2013, Volume: 14, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cisplatin; Combined Modality Therapy; Deoxycytidine; Egypt; Female; Gemcitabine; Humans; Lung Neoplasms; Male; Mesothelioma; Mesothelioma, Malignant; Middle Aged; Morphine; Pain; Palliative Care; Pleural Neoplasms; Quality of Life; Retrospective Studies; Survival; Survival Rate; Vinblastine; Vinorelbine	2013
[Acute pain at tumor recurrence site induced by vinorelbine infusion]. Kyobu geka. The Japanese journal of thoracic surgery, 2013, Volume: 66, Issue:7 Topics: Acute Disease; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Deoxycytidine; Gemcitabine; Humans; Lung Neoplasms; Male; Oxycodone; Pain; Vinblastine; Vinorelbine	2013
Patients with advanced disease: the value of patient reported outcomes. Oncology research and treatment, 2014, Volume: 37, Issue:1-2 Topics: Capecitabine; Deoxycytidine; Female; Fluorouracil; Gemcitabine; Humans; Karnofsky Performance Status; Male; Pain; Pancreatic Neoplasms; Quality of Life	2014
Does change in health-related quality of life score predict survival? Analysis of EORTC 08975 lung cancer trial. British journal of cancer, 2014, May-13, Volume: 110, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Clinical Trials, Phase III as Topic; Deglutition Disorders; Deoxycytidine; Gemcitabine; Humans; Interpersonal Relations; Lung Neoplasms; Multicenter Studies as Topic; Nausea; Paclitaxel; Pain; Palliative Care; Prognosis; Proportional Hazards Models; Quality of Life; Randomized Controlled Trials as Topic; Risk; Severity of Illness Index; Surveys and Questionnaires; Survival Analysis	2014
Coadministration of 5% glucose solution relieves vascular pain in the patients administered gemcitabine immediately. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2013, Volume: 19, Issue:2 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Glucose; Humans; Male; Middle Aged; Neoplasms; Pain; Treatment Outcome	2013
Use of low-dose combined therapy with gemcitabine and paclitaxel for advanced urothelial cancer patients with resistance to cisplatin-containing therapy: a retrospective analysis. Cancer chemotherapy and pharmacology, 2012, Volume: 70, Issue:3 Topics: Aged; Analgesics; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Feasibility Studies; Female; Gemcitabine; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Paclitaxel; Pain; Pain Measurement; Retrospective Studies; Salvage Therapy; Treatment Outcome; Urologic Neoplasms; Urothelium	2012
Vanilloids in pancreatic cancer: potential for chemotherapy and pain management. Gut, 2006, Volume: 55, Issue:4 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Apoptosis; Cell Division; Cell Line, Tumor; Chronic Disease; Deoxycytidine; Diterpenes; Drug Synergism; Drug Therapy, Combination; Female; Fluorouracil; Gemcitabine; Humans; Immunohistochemistry; Male; Middle Aged; Mitochondria; Oxidative Stress; Pain; Pancreas; Pancreatic Neoplasms; Pancreatitis; Prospective Studies; TRPV Cation Channels	2006
Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma. Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Oct-01, Volume: 11, Issue:19 Pt 1 Topics: Adolescent; Adult; Alkaline Phosphatase; Analgesics, Non-Narcotic; Antigens, CD34; Bone and Bones; Bone Neoplasms; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Humans; Image Processing, Computer-Assisted; Neoplasm Metastasis; Organometallic Compounds; Organophosphorus Compounds; Osteosarcoma; Pain; Positron-Emission Tomography; Radiation-Sensitizing Agents; Radiopharmaceuticals; Remission Induction; Samarium; Sarcoma; Stem Cells; Time Factors	2005
[Present and future home therapy in advanced stage of pancreatic cancer]. Gan to kagaku ryoho. Cancer & chemotherapy, 2006, Volume: 33, Issue:5 Topics: Ambulatory Care; Analgesics; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Fluorouracil; Forecasting; Gemcitabine; Home Care Services, Hospital-Based; Humans; Neoplasm Staging; Pain; Pancreatic Neoplasms; Quality of Life	2006
Analgesic effects of chemotherapy? Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1998, Volume: 16, Issue:2 Topics: Analgesics; Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Humans; Pain; Pancreatic Neoplasms	1998
Radiation myositis: the possible role of gemcitabine. Annals of oncology : official journal of the European Society for Medical Oncology, 2000, Volume: 11, Issue:12 Topics: Antimetabolites, Antineoplastic; Buttocks; Carcinoma, Squamous Cell; Combined Modality Therapy; Deoxycytidine; Disease Progression; Female; Gemcitabine; Humans; Lung Neoplasms; Magnetic Resonance Imaging; Middle Aged; Myositis; Pain; Radiotherapy; Tomography, X-Ray Computed	2000

chemdatabank.com